Company Filing History:
Years Active: 2015
Title: Young-Hoon Ji: Innovator in Anti-Inflammatory and Anti-Angiogenic Research
Introduction
Young-Hoon Ji is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-inflammatory and anti-angiogenic compositions. With a total of 2 patents, his work has the potential to impact various medical applications.
Latest Patents
Young-Hoon Ji's latest patents include an anti-inflammatory composition containing macrolactin A and its derivatives. This invention focuses on the anti-inflammatory properties of macrolactin compounds, which are derived from a novel strain of KJS-2 (KCCM10769P). The compounds have been shown to effectively suppress the expression of inducible nitric oxide synthetase (iNOS) and cyclooxygenase-2 (COX-2), which are crucial in the formation of inflammatory mediators. Additionally, these compounds inhibit the production of nitric oxide (NO) and prostaglandin E2 (PGE2), thereby providing excellent anti-inflammatory agents.
Another significant patent by Ji is an anti-angiogenic composition that also utilizes macrolactin A and its derivatives. This composition has demonstrated strong suppression of angiogenesis in in vivo experiments, indicating its potential as a pharmaceutical treatment for diseases associated with angiogenesis.
Career Highlights
Young-Hoon Ji is currently associated with Daewoo Pharmaceutical Ind. Co., Ltd., where he continues to innovate in the pharmaceutical sector. His research focuses on harnessing the therapeutic properties of macrolactin compounds, contributing to advancements in medical treatments.
Collaborations
Throughout his career, Young-Hoon Ji has collaborated with notable colleagues, including Dong-Hee Kim and Jae-Seon Kang. These collaborations have further enriched his research and development efforts in the pharmaceutical field.
Conclusion
Young-Hoon Ji is a dedicated inventor whose work in anti-inflammatory and anti-angiogenic research holds promise for future medical advancements. His contributions to the field are significant, and his ongoing research continues to pave the way for innovative pharmaceutical solutions.